ADMA Biologics Inc (ADMA): Total Asset Value of Company
Despite fierce competition with industry behemoths and the risk of synthetic analogs emerging, ADMA Biologics has achieved financial stability and a steady inflow of free cash. The total asset value visualizes the result of this transformation, where 621.40 represents the latest level. Resource stability is guaranteed by its own manufacturing plant in Florida, which ensures full control over drug production.
Comprehensive metric breakdowns and analytics for ADMA Bio (ADMA)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:ADMA, admabiologics.com
Total assets determine the aggregate resource potential of an enterprise, combining equity and liabilities to assess the scale of the business. By analyzing the volume of financial assets calculated reversely through return on assets (ROA), an investor can observe capitalization dynamics, which in the case of ADMA Biologics (ADMA) is supported by the ownership of unique plasma collection centers and patent-protected technologies under strict FDA control.
Competitors of ADMA Biologics (ADMA)
ARGX (argenx.com) - Company Total Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|Protagonist Therapeutics Inc (PTGX) - Company Total Assets|Aggregate Asset Value Immunovant Therapeutics (IMVT)|Company Total Assets KNSA (Kiniksa Pharmaceuticals)|grifols.com - Company Total Assets|Aggregate Company Assets Adaptive Biotechnologies Corporation (ADPT)|CLDX: Aggregate Asset Value|AUPH (Aurinia Pharma) - Aggregate Company Assets|BioCryst Corp (BCRX) - Cumulative Company Assets|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com (DNTH)|Pharvaris (PHVS) - Cumulative Company Assets|Aggregate Asset Value AbCellera Biologics (ABCL)|Company Total Assets TRML|Precigen Corp - Company Total Asset Base|PHAR: Aggregate Company Assets|NKTR: Cumulative Company Assets|UPB (Upstream Bio) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|IMNM (Immunome Corp) - Cumulative Company Assets|Company Total Assets GOSS|Aggregate Company Assets KalVista Pharmaceuticals KALV|Total Business Assets septerna.com (SEPN)|PVLA: Company Total Assets|Company Assets Savara Inc SVRA|Rigel Pharmaceuticals Inc - Company Total Assets|ANAB - Company Total Assets|Company Total Assets Astria Therapeutics|ENGN (engene.com) - Total Business Assets|Aggregate Company Assets RAPT|Cumulative Company Assets Aerovate|Company Total Assets ACRS|Company Total Assets Kyverna Therapeutics, Inc KYTX|Cumulative Company Assets Tiziana Life Sciences|Aggregate Asset Value cabalettabio.com CABA|VTYX - Company Total Assets|THTX - Aggregate Company Assets|Avalo Therapeutics Inc. - Company Total Assets|ELDN (Eledon Pharmaceuticals, Inc) - Company Total Asset Base|Aggregate Company Assets AGEN (Agenus)|Company Assets CLYM|Aggregate Company Assets Zura Bio (ZURA)|Aggregate Company Assets ATYR (aTyr Pharma Inc)|ADAG: Aggregate Company Assets|Company Assets ImageneBio IMA|Company Total Assets STTK|EQ - Company Balance Sheet Assets|connectbiopharm.com - Company Total Assets|Immunic (IMUX) - Company Total Asset Base|Company Total Assets ATRA|Cumulative Company Assets IFRX|XFOR (X4 Pharmaceuticals) - Aggregate Company Assets|Company Total Asset Base adicetbio.com (ACET)|Company Total Assets CELU (Celularity)|Company Total Assets INmune Bio Inc INMB|Barinthus Bio (BRNS) - Company Total Assets|KZR: Total Business Assets|SABS (SAB Biotherapeutics) - Aggregate Company Assets|akaritx.com (AKTX) - Cumulative Company Assets|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|Company Total Assets QTTB|GOVX - Aggregate Company Assets|Total Asset Value of Company Edesa Biotech Corp (EDSA)|Company Total Assets iBio, Inc.|Aggregate Asset Value Carisma Therapeutics Inc CARM|XTL Biopharmaceuticals Ltd. - Company Total Assets|BOLT: Company Total Assets|Aggregate Company Assets hcwbiologics.com HCWB|APVO (Aptevo Therapeutics Inc.) - Aggregate Asset Value|Aggregate Company Assets AIM|Cumulative Company Assets Aditxt Corp|Company Total Assets GRI|Company Total Assets XORTX Therapeutics Inc XRTX|Cumulative Company Assets ReShape Lifesciences|Aggregate Asset Value Revelation Biosciences Corp REVB|Company Total Assets INDP (Indaptus Therapeutics)|SCNI: Company Total Asset Base|CALI (calcimedica.com) - Aggregate Company Assets|AFMD (Affimed N.V.) - Cumulative Company Assets|Aggregate Company Assets ALLK|Cumulative Company Assets HOOKIPA (HOOK)|Cumulative Company Assets IGMS|Company Total Assets ITOS (iteostherapeutics.com)|OCEA - Aggregate Company Assets|Total Business Assets TC BioPharm (Holdings) Plc TCBP|THRD (Third Harmonic Bio, Inc) - Company Total Assets